Global API Leader Target pharmaceutical firms relying on large-scale API production and global supply chains. Harman Finochem’s status as a leading Metformin producer and 45+ APIs, with 75+ country reach, indicates strong capacity and reliability for CRAMS partnerships and long-term API supply agreements.

Quality and Compliance Leverage their multiple certifications (EDQM, WHO-GMP, USFDA, TGA, HPB-Canada, Japanese Ministry of Health) and cGMP-compliant facilities to position as a trusted supplier for regulated markets. Sales opportunities exist in pharma companies seeking compliant, auditable, risk-mitigated API sourcing.

R&D & Tech Transfer Highlight collaborative opportunities in API development, process optimization, and technology transfer. Their in-house R&D focus can support customers needing adapted or new APIs, reduced time-to-market, and scalable manufacturing solutions.

CRAMS & Partnerships Promote contract manufacturing and development services to global pharma players seeking cost-efficient, compliant manufacturing partners. The large production capacity and two GMP sites enable flexible scale-up for trial runs, pilots, and commercial demand.

Sustainability & Growth Position the company’s commitment to UN SDGs and global expansion as a differentiator for customers increasingly prioritizing ESG in supplier selection. Emphasize stable revenue footprint and growth potential in the API space as they continue to invest in capacity and quality.